Transfusion Reaction by Washed Red Blood Cell (RBC)

Orthopedic Disorder Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01934907
• Other study ID #: B-1307/212-009
• Status: Completed
• Phase: N/A
• First received: August 22, 2013
• Last updated: October 10, 2017
• Start date: August 2013
• Est. completion date: August 2016

Study information

• Verified date: October 2017
• Source: Seoul National University Bundang Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The hypothesis is that transfusion of washed red blood cell can decrease the complication by transfusion.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 9
• Est. completion date: August 2016
• Est. primary completion date: August 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients undergoing total hip replacement arthroplasty

Exclusion Criteria:

• Patients who do not agree with this clinical study.

• Patients who have a history of transfusion for recent 1 month.

• Patients who have rare blood types.

Related Conditions & MeSH terms

• Musculoskeletal Diseases
• Orthopedic Disorder

Intervention

Other:
• Washing of packed RBC by normal saline

Locations

Country	Name	City	State
Korea, Republic of	Seoul National University Bundang Hospital	Seongnam	Gyeonggi

Sponsors (1)

Lead Sponsor	Collaborator
Seoul National University Bundang Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Complication by transfusion		Operation day and during postoperative 5 days
Secondary	Total units of RBC transfused.		On the operation day and during the postoperative 5 days
Secondary	Hemoglobin		1 day before the operation day and postoperative 1 day